Riskpilot← Back to searchSign inGet full accessZedera Läkarkonsult AB
ABActiveOrg 5593566150Antenngatan 41 BGeneral medical practice activities · NACE 8621Est. 20210 employees
Revenue 2025
SEK 321K
+11% vs 2024
EBITDA margin
74.2%
+9% vs 2024
Equity ratio
71.2%
Financial strength
Net profit 2025
SEK 190K
+9% vs 2024
| Revenue | SEK 321K | +11% |
| EBITDA | SEK 238K | +9% |
| Net profit | SEK 190K | +9% |
| Total assets | SEK 338K | +7% |
| Equity | SEK 241K | +9% |
| Employees | 0 | — |
Legal name
Zedera Läkarkonsult AB
Org number
5593566150
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
23 december 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultverksamhet för vårdgivare så som tillhandahållande av läkartjänster nationellt och internationellt. Verksamheten innefattar medicinsk handläggning och vårdinriktade insatser.
Address
Antenngatan 41 B
Email
zederaab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 277 | 288 | 321 |
| Staff expenses | −6 | −3 | −9 |
| EBITDA | 217 | 219 | 238 |
| Depreciation & amort. | — | — | — |
| EBIT | 217 | 219 | 238 |
| Net financials | 0 | 1 | 1 |
| Profit before tax | 217 | 219 | 239 |
| Tax | −45 | −45 | −49 |
| Net profit | 172 | 174 | 190 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 282 | 317 | 338 |
| Equity | 197 | 221 | 241 |
| Long-term debt | — | — | — |
| Short-term debt | 85 | 96 | 98 |
| Total debt | 85 | 96 | 98 |
EBITDA margin
74.2%
This company
15.8%
Market median
+370% vs market
20232025
Equity ratio
71.2%
This company
38.2%
Market median
+86% vs market
20232025
Return on equity
78.7%
This company
18.4%
Market median
+328% vs market
20232025
Net profit margin
59.1%
This company
8.1%
Market median
+630% vs market
20232025
Asset turnover
0.95×
This company
1.12×
Market median
+15% vs market
20232025
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20232025
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (5) | ||
| Board of Directors | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Zedera Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lina Anna Elisabeth Nordström | Board of Directors | 0 companies |
| Mats Olov Gunnar Berggren | Deputy Board Member | 0 companies |
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Mats David Arby | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Jenny Therése Wilson | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Deputy Board Member | 0 companies |